These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3921296

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [Abstract] [Full Text] [Related]

  • 44. Effects of oral erythrosine (2',4',5',7'-tetraiodofluorescein) on the pituitary-thyroid axis in rats.
    Jennings AS, Schwartz SL, Balter NJ, Gardner D, Witorsch RJ.
    Toxicol Appl Pharmacol; 1990 May; 103(3):549-56. PubMed ID: 2160137
    [Abstract] [Full Text] [Related]

  • 45. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM, Taft JA, Reichlin S, Munsat TL.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):808-14. PubMed ID: 3091628
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Results of oral TRH test in the differentiation of compensated and decompensated autonomous thyroid nodules.
    Jüngst D, Büll U, Karl HJ.
    Klin Wochenschr; 1982 May 03; 60(9):477-8. PubMed ID: 6806525
    [Abstract] [Full Text] [Related]

  • 48. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
    Haug E, Frey HM, Sand T.
    Acta Endocrinol (Copenh); 1977 Jun 03; 85(2):335-44. PubMed ID: 405834
    [Abstract] [Full Text] [Related]

  • 49. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M, Alba-Roth J, Sobieszczyk S, Schopohl J, Müller OA, von Werder K.
    Acta Endocrinol (Copenh); 1989 Mar 03; 120(3):383-9. PubMed ID: 2494827
    [Abstract] [Full Text] [Related]

  • 50. Interaction between triiodothyronine and ovarian steroid hormones on the regulation of the release of thyrotropin and thyrotropin-releasing hormone in vitro.
    Liu SR, Tsai SC, Lu CC, Lee KY, Liu TC, Pu HF, Wang PS.
    Chin J Physiol; 1997 Dec 31; 40(4):221-6. PubMed ID: 9551251
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Serum concentrations of thyroxine and 3,5,3'-triiodothyronine in dogs before and after administration of freshly reconstituted or previously frozen thyrotropin-releasing hormone.
    Rosychuk RA, Freshman JL, Olson PN, Olson JD, Husted PW, Crowder-Sousa ME.
    Am J Vet Res; 1988 Oct 31; 49(10):1722-5. PubMed ID: 3142321
    [Abstract] [Full Text] [Related]

  • 53. Dynamics of serum thyrotropin and thyroid hormone changes in fasting.
    Spencer CA, Lum SM, Wilber JF, Kaptein EM, Nicoloff JT.
    J Clin Endocrinol Metab; 1983 May 31; 56(5):883-8. PubMed ID: 6403568
    [Abstract] [Full Text] [Related]

  • 54. [Indications for oral TRH in a study of 998 patients (author's transl)].
    Rinck PA, Botsch H, Rossdeutscher R.
    Rofo; 1981 Feb 31; 134(2):198-200. PubMed ID: 6452363
    [Abstract] [Full Text] [Related]

  • 55. Extrathyroidal effects of propylthiouracil and carbimazole on serum T4, T3, reverse T3 and TRH-induced TSH-release in man.
    Siersbaek-Nielsen K, Kirkegaard C, Rogowski P, Faber J, Lumholtz B, Friis T.
    Acta Endocrinol (Copenh); 1978 Jan 31; 87(1):80-7. PubMed ID: 413302
    [Abstract] [Full Text] [Related]

  • 56. Effects of acute and chronic administration of TRH on TSH and prolactin secretion in normal and hypothyroid rats.
    D'Angelo SA, Wall NR, Bowers CY, Rosa CG.
    Neuroendocrinology; 1975 Jan 31; 18(2):161-75. PubMed ID: 809721
    [Abstract] [Full Text] [Related]

  • 57. Dynorphin (1-13) effects on thyrotrophin-releasing hormone and thyrotrophin secretion in rats.
    Mitsuma T, Nogimori T.
    Acta Endocrinol (Copenh); 1983 Jul 31; 103(3):359-64. PubMed ID: 6410639
    [Abstract] [Full Text] [Related]

  • 58. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V, Volpi R, Capretti L, Caffarri G, Colla R, Chiodera P.
    J Investig Med; 1999 May 31; 47(5):227-31. PubMed ID: 10361382
    [Abstract] [Full Text] [Related]

  • 59. Thyrotropin and prolactin response to intraspinal TRH administration in man.
    Vigneri R, Pezzino V, Filetti S, Squatrito S, Corso A, Maricchiolo M, Polosa P, Scapagnini U.
    Neuroendocrinology; 1977 May 31; 23(3):171-80. PubMed ID: 408727
    [Abstract] [Full Text] [Related]

  • 60. The TSH response to thyrotropin-releasing hormone (TRH) in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones.
    Sawin CT, Hershman JM.
    J Clin Endocrinol Metab; 1976 May 31; 42(5):809-16. PubMed ID: 818102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.